These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Staphylococcus haemolyticus with reduced susceptibility to vancomycin isolated from a patient with neonatal meningitis in a Mexican medical facility]. Reyna-Figueroa J, Ramírez-Landin A, Villeda-Gabriel G, Ortiz-Ibarra FJ. Gac Med Mex; 2007 Dec 21; 143(2):163-5. PubMed ID: 17585704 [Abstract] [Full Text] [Related]
28. Low-level resistance to glycopeptides amongst staphylococcus species: surveillance in a university hospital and evaluation of a vancomycin screening agar. Park YJ, Jun Park J, Lee SO, Oh EJ, Kee Kim B. Diagn Microbiol Infect Dis; 2001 Nov 21; 41(3):155-9. PubMed ID: 11750170 [Abstract] [Full Text] [Related]
29. Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus. Mohammedi I, Malhière S, Robert D, Charveriat MA, Etienne J. Infection; 2006 Oct 21; 34(5):292-3. PubMed ID: 17033757 [No Abstract] [Full Text] [Related]
32. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci. Bergeret M, Boutros N, Raymond J. Int J Antimicrob Agents; 2004 Mar 21; 23(3):247-53. PubMed ID: 15164965 [Abstract] [Full Text] [Related]
39. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS, Pavlov AY, Olsufyeva EN, Mirchink EP, Preobrazhenskaya MN. J Med Chem; 2003 Mar 27; 46(7):1204-9. PubMed ID: 12646030 [Abstract] [Full Text] [Related]